Willingness-to-Pay and Benefit–Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey

PURPOSE: Botulinum toxin (BTX) is a new treatment approach primarily aimed at relieving flushing and erythema for rosacea, but it is expensive and lacks economic benefit evaluation studies.This study aimed to investigate willingness-to-pay (WTP) of BTX treatment and conduct benefit–cost analysis (BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xizhao, Ouyang, Yuyan, Deng, Yuxuan, Xiao, Yi, Tang, Yan, Jian, Dan, Li, Ji, Xie, Hongfu, Huang, Yingxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185460/
https://www.ncbi.nlm.nih.gov/pubmed/34113082
http://dx.doi.org/10.2147/PPA.S311322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185460/
https://www.ncbi.nlm.nih.gov/pubmed/34113082
http://dx.doi.org/10.2147/PPA.S311322

Ejemplares similares